Aridis Pharmaceuticals, Inc.
5941 Optical Court
92 articles with Aridis Pharmaceuticals, Inc.
Aridis Pharmaceuticals Receives FDA Fast Track Designation For AR-301 For Acute Pneumonia Caused By Staphylococcus Aureus
Aridis Pharmaceuticals Expands Phase 2a Trial Into The U.S. For Monoclonal Antibody AR-301 For The Treatment Of Acute Pneumonia
Aridis Pharmaceuticals Receives FDA Fast Track Designation For Aerucin For Treating Hospital-Acquired And Ventilator-Associated Pneumonia
Aridis Pharmaceuticals Commences Phase 1 Clinical Study Of Aerucin Monoclonal Antibody For Acute Pneumonia
Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech
EnWave Corporation and Aridis Pharmaceuticals Sign Collaboration Agreement-Relationship Expanded to Include Antibodies